NEW Delhi: India announced Tuesday a partial lifting of a fresh export ban on a malaria drug seen as a potential coronavirus treatment, after US President Donald Trump hinted at "retaliation".
Citing domestic needs, India banned on Saturday exports of hydroxychloroquine which has shown early promise against COVID-19 in small-scale studies in France and China. India is the world’s largest producer and exporter of the drug, according to media reports.
Global stocks are however limited and Trump said that he had pressed Indian Prime Minister Narendra Modi this weekend to expedite shipments, hinting at consequences otherwise. "If he doesn’t allow it to come out, he doesn’t allow it to come out, that would be okay, but of course, there may be retaliation, why wouldn’t there be?" Trump said on Monday.
Boxes of Tecentriq from Genentech are seen at the Huntsman Cancer Institute at the University of Utah in Salt Lake...
Tahawwur Hussain Rana , 66, was brought to India from the United States on Thursday. — AFP/File NEW DELHI: Indian...
Towana Looney is seen in NYU Langone Hospital in New York on December 11, 2024, just weeks after receiving a...
Germany's Defence Minister Boris Pistorius, Ukraine's Minister of Defence Rustem Umerov and Britain's Defence...
US envoy Steve Witkoff meeting Russian President Vladimir Putin in Saint Petersburg. — AFP/FileMOSCOW: US President...
A statue of Lady Justice at the Court of Final Appeal is pictured, in Hong Kong, China, September 5, 2023. —...
